Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Slc35e2b | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC35E2B mRNA] | CTD | PMID:31150632 | Slc35e2b | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Slc35e2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC35E2 mRNA | CTD | PMID:36331819 | Slc35e2b | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of SLC35E2 mRNA | CTD | PMID:22206623 | Slc35e2b | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of SLC35E2B mRNA | CTD | PMID:29097150 | Slc35e2b | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of SLC35E2B mRNA | CTD | PMID:32145629 | Slc35e2b | Rat | 17beta-estradiol | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Estradiol results in decreased expression of SLC35E2 mRNA | CTD | PMID:39298647 | Slc35e2b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC35E2 mRNA | CTD | PMID:19770486 | Slc35e2b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC35E2B mRNA | CTD | PMID:32109520 | Slc35e2b | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SLC35E2 mRNA | CTD | PMID:20188158|PMID:26251327 | Slc35e2b | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Slc35e2b | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of SLC35E2 mRNA | CTD | PMID:39298647 | Slc35e2b | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of SLC35E2B mRNA | CTD | PMID:28973697 | Slc35e2b | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of SLC35E2B mRNA | CTD | PMID:31881176 | Slc35e2b | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of SLC35E2B mRNA | CTD | PMID:28959563 | Slc35e2b | Rat | aflatoxin B1 | increases methylation | ISO | SLC35E2B (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of SLC35E2B gene | CTD | PMID:27153756 | Slc35e2b | Rat | arsane | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slc35e2b | Rat | arsenic atom | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slc35e2b | Rat | benzo[a]pyrene | increases methylation | ISO | SLC35E2B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SLC35E2 5' UTR | CTD | PMID:27901495 | Slc35e2b | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC35E2B mRNA | CTD | PMID:25181051 | Slc35e2b | Rat | bisphenol A | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SLC35E2 mRNA | CTD | PMID:32156529 | Slc35e2b | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SLC35E2B mRNA | CTD | PMID:32145629 | Slc35e2b | Rat | bisphenol A | increases expression | ISO | SLC35E2B (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SLC35E2 mRNA | CTD | PMID:29275510 | Slc35e2b | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC35E2B mRNA | CTD | PMID:29097150 | Slc35e2b | Rat | bisphenol F | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Slc35e2b | Rat | butanal | decreases expression | ISO | SLC35E2B (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of SLC35E2B mRNA | CTD | PMID:26079696 | Slc35e2b | Rat | cadmium atom | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC35E2B more ... | CTD | PMID:35301059 | Slc35e2b | Rat | cadmium dichloride | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC35E2B more ... | CTD | PMID:35301059 | Slc35e2b | Rat | chromium(6+) | affects expression | ISO | Slc35e2 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of SLC35E2 mRNA | CTD | PMID:28472532 | Slc35e2b | Rat | clofibrate | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of SLC35E2 mRNA | CTD | PMID:23811191 | Slc35e2b | Rat | crocidolite asbestos | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Asbestos, Crocidolite results in decreased expression of SLC35E2 mRNA | CTD | PMID:29279043 | Slc35e2b | Rat | cyclosporin A | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of SLC35E2 mRNA | CTD | PMID:19770486 | Slc35e2b | Rat | dexamethasone | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Slc35e2b | Rat | dibutyl phthalate | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of SLC35E2 mRNA | CTD | PMID:21266533 | Slc35e2b | Rat | dicrotophos | increases expression | ISO | SLC35E2B (Homo sapiens) | 6480464 | dicrotophos results in increased expression of SLC35E2B mRNA | CTD | PMID:28302478 | Slc35e2b | Rat | dorsomorphin | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Slc35e2b | Rat | epoxiconazole | increases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SLC35E2 mRNA | CTD | PMID:35436446 | Slc35e2b | Rat | fenthion | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Fenthion results in decreased expression of SLC35E2 mRNA | CTD | PMID:34813904 | Slc35e2b | Rat | folic acid | increases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Folic Acid results in increased expression of SLC35E2 mRNA | CTD | PMID:25629700 | Slc35e2b | Rat | gallic acid | decreases expression | ISO | SLC35E2B (Homo sapiens) | 6480464 | Gallic Acid results in decreased expression of SLC35E2B mRNA | CTD | PMID:34408198 | Slc35e2b | Rat | indometacin | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Slc35e2b | Rat | leflunomide | decreases expression | ISO | SLC35E2B (Homo sapiens) | 6480464 | leflunomide results in decreased expression of SLC35E2B mRNA | CTD | PMID:28988120 | Slc35e2b | Rat | manganese atom | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slc35e2b | Rat | manganese(0) | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slc35e2b | Rat | manganese(II) chloride | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slc35e2b | Rat | okadaic acid | decreases expression | ISO | SLC35E2B (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of SLC35E2B mRNA | CTD | PMID:38832940 | Slc35e2b | Rat | paracetamol | decreases expression | ISO | SLC35E2B (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SLC35E2B mRNA | CTD | PMID:21420995 | Slc35e2b | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SLC35E2B mRNA | CTD | PMID:33387578 | Slc35e2b | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slc35e2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC35E2 mRNA | CTD | PMID:36331819 | Slc35e2b | Rat | pirinixic acid | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of SLC35E2 mRNA | CTD | PMID:23811191 | Slc35e2b | Rat | SB 431542 | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Slc35e2b | Rat | sodium arsenite | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Slc35e2b | Rat | sunitinib | increases expression | ISO | SLC35E2B (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SLC35E2B mRNA | CTD | PMID:31533062 | Slc35e2b | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SLC35E2B mRNA | CTD | PMID:31150632 | Slc35e2b | Rat | tetrachloromethane | decreases expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of SLC35E2 mRNA | CTD | PMID:31919559 | Slc35e2b | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC35E2B mRNA] | CTD | PMID:31150632 | Slc35e2b | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SLC35E2B mRNA | CTD | PMID:34492290 | Slc35e2b | Rat | titanium dioxide | affects methylation | ISO | Slc35e2 (Mus musculus) | 6480464 | titanium dioxide affects the methylation of SLC35E2 gene | CTD | PMID:35295148 | Slc35e2b | Rat | valproic acid | increases methylation | ISO | SLC35E2B (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SLC35E2B gene | CTD | PMID:29154799 | Slc35e2b | Rat | valproic acid | decreases expression | ISO | SLC35E2B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SLC35E2B mRNA | CTD | PMID:23179753|PMID:26272509|PMID:28001369 | Slc35e2b | Rat | valproic acid | multiple interactions | ISO | SLC35E2B (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Slc35e2b | Rat | valproic acid | affects expression | ISO | Slc35e2 (Mus musculus) | 6480464 | Valproic Acid affects the expression of SLC35E2 mRNA | CTD | PMID:17292431 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





















